As insurers, employers, and state programs reassess cost exposure, coverage policies continue to tighten particularly for weight loss alone
Despite the difference in dosing frequency, a study published in the journal Diabetes Care found that both of these medications were equally effective in reducing HbA1c levels, and there was no significant difference in weight loss between the two groups
What's our tariff exposure if supply chains shift
Crystal Broussard, MD, is a board-certified family physician and a Fellow of the American Board of Obesity Medicine
Tomat AL, Inserra F, Veiras L, Vallone MC, Balaszczuk AM, Costa MA, et al